research A Woman With Iatrogenic Androgenetic Alopecia Responding To Finasteride
EF and PXE not closely related.
Search
for
Sort by
Research
300-330 / 1000+ results 
research Clinical Experiences on Alopecia Areata Treatment with Tofacitinib: A Study of 63 Patients
Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.
research Medical Treatment of Non-Scarring Alopecia
Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.
research An Analysis of Gene Expression Data Involving Examination of Signaling Pathways Activation Reveals New Insights into the Mechanism of Action of Minoxidil Topical Foam in Men with Androgenetic Alopecia
Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.
research SOX4 Is Essential for Melanoma Tumorigenesis
SOX4 is crucial for the development of melanoma.
research Rapid Hair Regrowth in an Alopecia Universalis Patient With Deucravacitinib: A Case Report
A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.
research Effects of an Online Educational Curriculum on Knowledge and Competence in Managing Onychomycosis
Online medical education helps doctors better understand and treat nail fungus.
research Drug Discovery for Alopecia: Gone Today, Hair Tomorrow
Topical drugs and near-infrared light therapy show potential for treating alopecia.
research Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Areata: A Randomized Double-Blinded Parallel-Group Study
The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.
research Diagnostic Approach and Management of Androgenetic Alopecia
Effective treatments for common hair loss are limited and may have side effects, leading to patient disappointment and treatment discontinuation.
research Androgenetic Alopecia in COVID-19: Compared to What?
Hair loss link to severe COVID-19 unclear.
research Androgenetic Alopecia in Women
Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.
research Male Androgenetic Alopecia
Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.
research Winding the Clock Back on Female Androgenetic Alopecia
Reversing female hair loss.
research JAAD Grand Rounds Quiz on Dermatological Conditions
The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.
research Comment on 'Treatment of Male Pattern Alopecia with Platelet-Rich Plasma: A Double-Blind Controlled Study with Analysis of Platelet Number and Growth Factor Levels'
The comment questions the study's methods for diagnosing hair loss, the type of injections used, the reliability of hair count as a measure, the lack of detail about the procedure, and disagrees with the conclusion about the effect of needling.
research Male Androgenetic Alopecia and Cardiovascular Risk Factors
Men with male pattern baldness are more likely to have heart disease risk factors, so they should get heart screenings early.
research Hair Loss Is an Important Symptom of Menopause
Many women experience significant hair loss during menopause, and topical minoxidil is an effective treatment.
research Psychological Impact and Awareness of Androgenetic Alopecia Among Filipino Male Patients Aged 18 to 65 Seen at the Outpatient Department of the Ospital ng Maynila Medical Center, Department of Dermatology
Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.
research Androgenetic Alopecia (Male Pattern Hair Loss) in the United States: What Treatments Should Primary Care Providers Recommend?
Use minoxidil or finasteride first, then try HairMax LaserComb if needed.
research Recurring Transient Lymphadenopathy After Microneedling With Platelet-Rich Plasma for Androgenetic Alopecia
Microneedling with platelet-rich plasma can cause temporary, painful lymph node swelling in some patients.
research Active Ingredients and Procedures in Androgenetic Alopecia
The review found that PRP is the most effective treatment for hair loss with few side effects.
research Very-Low-Dose Oral Minoxidil in Male Androgenetic Alopecia: A Study with Quantitative Trichoscopic Documentation
Low-dose oral minoxidil improved or stabilized hair loss in some patients, but higher doses may be needed for significant effects.
research Hair Loss in Women
Up to half of women by age 50 experience significant hair loss, with various types and treatments available.
research Quality of Life and Its Association With Androgenetic Alopecia Patients in Shanghai: A Cross-Sectional Study
Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.
research Therapeutic Experience with Oral Finasteride for Androgenetic Alopecia in Female-to-Male Transgender Patients
Finasteride effectively treats hair loss in transgender men with few side effects.
research A Study of the Geheimratsacken Angle as Predictor for Early Diagnosis of Androgenetic Alopecia in Adolescent Population
research Editorial: Advances in Evaluation and Management of Hair Loss Disorders
Early diagnosis and personalized treatments are crucial for better hair loss management.
research Is Autologous Platelet-Rich Plasma Capable of Increasing Hair Density in Patients with Androgenic Alopecia? A Systematic Review and Meta-Analysis of Randomized Clinical Trials
PRP injections can increase hair density in people with androgenic alopecia.
research Comparison of Treatment with Clobetasol Propionate 0.05% and Topical Pimecrolimus 1% in Alopecia Areata
Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.